These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Neurologic current topics]. Autret A Rev Prat; 1983 Feb; 33(11):477-80, 485-7. PubMed ID: 6133342 [No Abstract] [Full Text] [Related]
12. [Prevention of tardive dyskinesia caused by neuroleptic therapy]. Perényi A Orv Hetil; 1981 Jul; 122(27):1627-30. PubMed ID: 6117046 [No Abstract] [Full Text] [Related]
13. [Neurologic adverse manifestations and complications of ambulatory therapy with psychotropic drugs in the late stages]. Makeeva VL Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):178-82. PubMed ID: 636711 [TBL] [Abstract][Full Text] [Related]
14. Tardive dyskinesia: barriers to the professional recognition of an iatrogenic disease. Brown P; Funk SC J Health Soc Behav; 1986 Jun; 27(2):116-32. PubMed ID: 2874170 [No Abstract] [Full Text] [Related]
15. [Complications observed during use of lithium salt-neuroleptic combinations; comparative study of clinical evolution, EEG and pharmacokinetics]. Granier F; Girard M; Loustalan JM; Thomas J; Escande M Ann Med Psychol (Paris); 1983; 141(8):891-908. PubMed ID: 6141759 [No Abstract] [Full Text] [Related]
16. [Neuropathy due to drug therapy]. Kato Y Nihon Rinsho; 1970 Mar; 28(3):505-9. PubMed ID: 4315541 [No Abstract] [Full Text] [Related]
17. [Persistent neurological syndrome after treatment with lithium salts. Toxicity of the lithium-neuroleptic combination?]. Habib M; Khalil R; le Pensec-Bertrand D; Ali-Cherif A; Bongrand MC; Crevat A Rev Neurol (Paris); 1986; 142(1):61-4. PubMed ID: 2871617 [TBL] [Abstract][Full Text] [Related]
18. Guidelines for combination of lithium and neuroleptics. Campbell HD; Moffic HS Tex Med; 1983 Sep; 79(9):60-2. PubMed ID: 6138872 [No Abstract] [Full Text] [Related]